• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种新型I-125固体核心近距离放射治疗源的剂量学参数。

Dosimetric parameters of three new solid core I-125 brachytherapy sources.

作者信息

Solberg Timothy D, DeMarco John J, Hugo Geoffrey, Wallace Robert E

机构信息

Department of Radiation Oncology, UCLA School of Medicine, Los Angeles, California 98095-6951, USA.

出版信息

J Appl Clin Med Phys. 2002 Spring;3(2):119-34. doi: 10.1120/jacmp.v3i2.2576.

DOI:10.1120/jacmp.v3i2.2576
PMID:11958652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5724609/
Abstract

Monte Carlo calculations and TLD measurements have been performed for the purpose of characterizing dosimetric properties of new commercially available brachytherapy sources. All sources tested consisted of a solid core, upon which a thin layer of 125I has been adsorbed, encased within a titanium housing. The PharmaSeed BT-125 source manufactured by Syncor is available in silver or palladium core configurations while the ADVANTAGE source from IsoAid has silver only. Dosimetric properties, including the dose rate constant, radial dose function, and anisotropy characteristics were determined according to the TG-43 protocol. Additionally, the geometry function was calculated exactly using Monte Carlo and compared with both the point and line source approximations. The 1999 NIST standard was followed in determining air kerma strength. Dose rate constants were calculated to be 0.955+/-0.005, 0.967+/-0.005, and 0.962+/-0.005 cGy h(-1) x U(-1) for the PharmaSeed BT-125-1, BT-125-2, and ADVANTAGE sources, respectively. TLD measurements were in excellent agreement with Monte Carlo calculations. Radial dose function, g(r), calculated to a distance of 10 cm, and anisotropy function, F(r,theta), calculated for radii from 0.5 to 7.0 cm, were similar among all source configurations. Anisotropy constants, phi(an), were calculated to be 0.941, 0.944, and 0.960 for the three sources, respectively. All dosimetric parameters were found to be in close agreement with previously published data for similar source configurations. The MCNP Monte Carlo code appears to be ideally suited to low energy dosimetry applications.

摘要

为了表征新型市售近距离放射治疗源的剂量学特性,已进行了蒙特卡罗计算和热释光剂量计(TLD)测量。所有测试的源均由实心芯组成,在其上吸附了一层薄薄的125I,并封装在钛外壳内。Syncor制造的PharmaSeed BT - 125源有银芯或钯芯配置,而IsoAid的ADVANTAGE源只有银芯。根据TG - 43协议确定了剂量学特性,包括剂量率常数、径向剂量函数和各向异性特征。此外,使用蒙特卡罗精确计算了几何函数,并与点源和线源近似值进行了比较。在确定空气比释动能强度时遵循了1999年美国国家标准与技术研究院(NIST)标准。PharmaSeed BT - 125 - 1、BT - 125 - 2和ADVANTAGE源的剂量率常数分别计算为0.955±0.005、0.967±0.005和0.962±0.005 cGy h(-1) x U(-1)。TLD测量结果与蒙特卡罗计算结果非常吻合。所有源配置的径向剂量函数g(r)计算到10 cm距离,以及各向异性函数F(r,θ)计算半径从0.5到7.0 cm,结果相似。三种源的各向异性常数φ(an)分别计算为0.941、0.944和0.960。发现所有剂量学参数与先前发表的类似源配置数据非常吻合。MCNP蒙特卡罗代码似乎非常适合低能剂量学应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/27fd041c17f4/ACM2-3-119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/171b351a6943/ACM2-3-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/3932ee7832a8/ACM2-3-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/579d51712a88/ACM2-3-119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/27fd041c17f4/ACM2-3-119-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/171b351a6943/ACM2-3-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/3932ee7832a8/ACM2-3-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/579d51712a88/ACM2-3-119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a5/5724609/27fd041c17f4/ACM2-3-119-g004.jpg

相似文献

1
Dosimetric parameters of three new solid core I-125 brachytherapy sources.三种新型I-125固体核心近距离放射治疗源的剂量学参数。
J Appl Clin Med Phys. 2002 Spring;3(2):119-34. doi: 10.1120/jacmp.v3i2.2576.
2
Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
Med Phys. 2002 May;29(5):662-8. doi: 10.1118/1.1469627.
3
Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.125I(IR-Seed2型)近距离放射治疗源的TG-43U1推荐剂量学参数的蒙特卡罗计算与实验测量
J Appl Clin Med Phys. 2016 Jul 8;17(4):430-441. doi: 10.1120/jacmp.v17i4.6127.
4
Dosimetric characteristics of the Pharma Seed model BT-125-I source.制药种子模型BT-125-I源的剂量学特性。
Med Phys. 2000 Sep;27(9):2174-81. doi: 10.1118/1.1289897.
5
The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.新型GAFCHROMIC EBT薄膜在固体水模体中用于¹²⁵I粒子剂量测定的应用
Med Phys. 2008 Aug;35(8):3787-99. doi: 10.1118/1.2955746.
6
Dosimetric characterization of GMS BT-125-1 I radioactive seed with Monte Carlo simulations and experimental measurement.采用蒙特卡罗模拟和实验测量对GMS BT - 125 - 1 I放射性种子进行剂量学表征。
J Appl Clin Med Phys. 2017 Nov;18(6):49-57. doi: 10.1002/acm2.12173. Epub 2017 Sep 14.
7
Dosimetric characteristics of the InterSource103 palladium brachytherapy source.InterSource103 钯近距离放射治疗源的剂量学特征。
Med Phys. 2000 May;27(5):1093-100. doi: 10.1118/1.598991.
8
Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.selectSeed 125I 组织间近距离治疗种子源的蒙特卡罗剂量测定法
Med Phys. 2001 Aug;28(8):1753-60. doi: 10.1118/1.1384460.
9
Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.IsoAid ADVANTAGE 125I近距离放射治疗源剂量学特性的实验与理论测定
Med Phys. 2002 Sep;29(9):2152-8. doi: 10.1118/1.1500395.
10
Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.使用蒙特卡罗模拟对IsoAid ADVANTAGE (125)I近距离放射治疗源剂量学参数的研究。
Appl Radiat Isot. 2010 Jan;68(1):211-3. doi: 10.1016/j.apradiso.2009.08.007. Epub 2009 Aug 25.

引用本文的文献

1
Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy.用于眼敷贴近距离治疗中新型 I-125 籽源模拟与剂量测定的 GATE 蒙特卡罗代码的开发
Nucl Med Mol Imaging. 2021 Apr;55(2):86-95. doi: 10.1007/s13139-020-00680-5. Epub 2021 Jan 11.
2
Dosimetric characterization of GMS BT-125-1 I radioactive seed with Monte Carlo simulations and experimental measurement.采用蒙特卡罗模拟和实验测量对GMS BT - 125 - 1 I放射性种子进行剂量学表征。
J Appl Clin Med Phys. 2017 Nov;18(6):49-57. doi: 10.1002/acm2.12173. Epub 2017 Sep 14.
3
Dosimetric Study of Biliary Stent Loaded with Radioactive I Seeds.

本文引用的文献

1
Model 3500 125I brachytherapy source dosimetric characterization.3500型125I近距离放射治疗源的剂量学特性
Appl Radiat Isot. 2002 Apr;56(4):581-7. doi: 10.1016/s0969-8043(01)00254-8.
2
Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source.蒙特卡洛辅助的源技术医疗模型STM1251 I-125组织间近距离放射治疗源剂量测定法
Med Phys. 2001 May;28(5):764-72. doi: 10.1118/1.1367280.
3
Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source.
载有放射性碘籽源的胆道支架剂量学研究
Chin Med J (Engl). 2017 May 5;130(9):1093-1099. doi: 10.4103/0366-6999.204936.
4
Comparison of TG-43 dosimetric parameters of brachytherapy sources obtained by three different versions of MCNP codes.通过三种不同版本的MCNP代码获得的近距离放射治疗源的TG-43剂量学参数比较。
J Appl Clin Med Phys. 2016 Mar 8;17(2):379-390. doi: 10.1120/jacmp.v17i2.5797.
5
Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.使用斑块模拟器和蒙特卡罗模拟对Eye Physics EP917巩膜眼斑块剂量测定进行比较
J Appl Clin Med Phys. 2015 Nov 8;16(6):226-239. doi: 10.1120/jacmp.v16i6.5659.
6
Monte Carlo investigation of energy response of various detector materials in ¹²⁵I and ¹⁶⁹Yb brachytherapy dosimetry.¹²⁵I 和 ¹⁶⁹Yb 近距离治疗剂量学中各种探测器材料能量响应的蒙特卡罗研究。
J Appl Clin Med Phys. 2010 Jul 28;11(4):3282. doi: 10.1120/jacmp.v11i4.3282.
Med Phys. 2001 Apr;28(4):661-70. doi: 10.1118/1.1357456.
4
Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantom.模型 I125-SL 125碘近距离放射治疗源在体模中的经验剂量学特征。
Med Phys. 2000 Dec;27(12):2796-802. doi: 10.1118/1.1323980.
5
Dosimetric characteristics of the Pharma Seed model BT-125-I source.制药种子模型BT-125-I源的剂量学特性。
Med Phys. 2000 Sep;27(9):2174-81. doi: 10.1118/1.1289897.
6
Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice.2222例T1-2期前列腺肿瘤患者单纯近距离放疗或单纯外照射放疗后的无失败生存期:单中心研究结果
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):111-7. doi: 10.1016/s0360-3016(00)00598-8.
7
Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.经会阴CT引导下I-125粒子永久植入治疗局限性前列腺癌患者的五年生化转归及毒性反应
Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1261-6. doi: 10.1016/s0360-3016(00)00550-2.
8
Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy.
Med Phys. 2000 May;27(5):1086-92. doi: 10.1118/1.598973.
9
On the use of apparent activity (Aapp) for treatment planning of 125I and 103Pd interstitial brachytherapy sources: recommendations of the American Association of Physicists in Medicine radiation therapy committee subcommittee on low-energy brachytherapy source dosimetry.关于使用表观活度(Aapp)进行¹²⁵I和¹⁰³Pd组织间近距离放射治疗源的治疗计划:美国医学物理学家协会放射治疗委员会低能近距离放射治疗源剂量测定小组委员会的建议
Med Phys. 1999 Dec;26(12):2529-30. doi: 10.1118/1.598789.
10
CT-based dosimetry calculations for 125I prostate implants.
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1347-53. doi: 10.1016/s0360-3016(99)00343-0.